CSWM
ABBV icon

Cassady Schiller Wealth Management’s AbbVie ABBV Stock Holding History

Cassady Schiller Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$478K Buy
2,689
+80
+3% +$14.7K 0.18% 71
2024
Q3 		$515K Sell
2,609
-333
-11% -$62.1K 0.19% 70
2024
Q2 		$505K Sell
2,942
-37
-1% -$6.13K 0.21% 64
2024
Q1 		$543K Buy
2,979
+59
+2% +$10.2K 0.24% 62
2023
Q4 		$453K Sell
2,920
-130
-4% -$19K 0.23% 65
2023
Q3 		$455K Buy
3,050
+177
+6% +$26K 0.25% 63
2023
Q2 		$387K Buy
2,873
+333
+13% +$48.8K 0.21% 73
2023
Q1 		$405K Sell
2,540
-46
-2% -$7.03K 0.19% 71
2022
Q4 		$418K Sell
2,586
-420
-14% -$64.4K 0.26% 69
2022
Q3 		$403K Buy
3,006
+298
+11% +$42.8K 0.23% 69
2022
Q2 		$415K Buy
2,708
+36
+1% +$5.5K 0.22% 64
2022
Q1 		$433K Buy
2,672
+1,330
+99% +$193K 0.21% 69
2021
Q4 		$182K Buy
+1,342
New +$159K 0.11% 105

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cassady Schiller Wealth Management's ABBV Position: Q4 2024 in Review

Cassady Schiller Wealth Management increased its AbbVie (ABBV) stake by 3.1% in Q4 2024, buying an estimated $14.7K and bringing the position to 2,689 shares worth $478K. The position accounts for 0.18% of the portfolio, ranked #71.

Cassady Schiller Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 13 quarters since. The position peaked at $543K in Q1 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Cassady Schiller Wealth Management held 2,689 shares of AbbVie worth $478K as of Q4 2024.
  • Cassady Schiller Wealth Management bought 80 AbbVie shares in Q4 2024, an estimated $14.7K.
  • AbbVie made up 0.18% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #71 holding.
  • Cassady Schiller Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 13 quarters since.
  • Cassady Schiller Wealth Management's AbbVie position peaked at $543K in Q1 2024.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.